Nasus Pharma Ltd (NSRX)

CIK 2029039 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nasus Pharma Ltd.

Recent SEC filings

FiledFormAccession number
Oct 19, 2026S-80001493152-26-047602
Oct 8, 20266-K0001493152-26-046340
Sep 23, 202630001493152-26-043796
Sep 21, 202640001493152-26-043559
Sep 18, 20266-K0001493152-26-043342
Sep 18, 2026424B50001493152-26-043370
Sep 14, 20266-K0001493152-26-042488
Sep 11, 2026EFFECT9999999995-26-002954
Sep 4, 20266-K0001493152-26-041534
Sep 1, 2026F-30001493152-26-041040
Aug 20, 2026EFFECT9999999995-26-002715
Aug 19, 2026POS AM0001493152-26-039052
Aug 19, 20266-K0001493152-26-039148
Aug 17, 20266-K0001493152-26-038651
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003431
Jul 31, 202630001493152-26-035646
Jul 29, 202640001493152-26-035218
Jul 28, 20266-K0001493152-26-034938
Jun 22, 202640001493152-26-029484
Jun 9, 20266-K0001493152-26-027929
May 26, 2026S-80001493152-26-025278
May 15, 2026SCHEDULE 13G0001193125-26-225115
Apr 22, 202640001493152-26-018607
Apr 7, 2026SCHEDULE 13G0002073679-26-000045
Apr 1, 202640001493152-26-014503